International multicentre randomized controlled trial of G17DT in patients with advanced pancreatic cancer

Trial Profile

International multicentre randomized controlled trial of G17DT in patients with advanced pancreatic cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2012

At a glance

  • Drugs Polyclonal antibody stimulator (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2012 Final results published in the Pancreas.
    • 05 Nov 2010 New trial record.
    • 01 May 2001 Recruitment initiated.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top